Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nader El-Sayes

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Cells|April 23, 2020
Hypoxia-Driven Immune Escape in the Tumor MicroenvironmentAlyssa Vito, Nader El-Sayes, Karen Mossman
International Journal of Molecular Sciences|June 2, 2021
Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected CellsHadia Farrukh, Nader El-Sayes, Karen Mossman
Cancers|March 6, 2021
Tumor Heterogeneity: A Great Barrier in the Age of Cancer ImmunotherapyNader El-Sayes, Alyssa Vito, Karen Mossman
Cancers|November 13, 2021
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast CancerAlyssa Vito, Nader El-Sayes, Omar Salem, et al.
International Journal of Molecular Sciences|June 2, 2021
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast CancerAlyssa Vito, Stephanie Rathmann, Natalie Mercanti, et al.
International Journal of Molecular Sciences|February 15, 2022
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent MannerNader El-Sayes, Alyssa Vito, Omar Salem, et al.
Molecular Therapy Oncolytics|April 11, 2022
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activityNader El-Sayes, Scott Walsh, Alyssa Vito, et al.
Methods in Enzymology|March 4, 2020
Genetic modification of oncolytic viruses to enhance antitumor immunityMaria Eugenia Davola, Alyssa Vito, Jiarun Wei, et al.
Cancers|February 25, 2023
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory CellsMaria Eugenia Davola, Olga Cormier, Alyssa Vito, et al.
Cancer Immunology Research|October 8, 2024
Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T CellsLi Deng, Scott R Walsh, Andrew Nguyen, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Cells|April 23, 2020
Hypoxia-Driven Immune Escape in the Tumor MicroenvironmentAlyssa Vito, Nader El-Sayes, Karen Mossman
International Journal of Molecular Sciences|June 2, 2021
Mechanisms of PD-L1 Regulation in Malignant and Virus-Infected CellsHadia Farrukh, Nader El-Sayes, Karen Mossman
Cancers|March 6, 2021
Tumor Heterogeneity: A Great Barrier in the Age of Cancer ImmunotherapyNader El-Sayes, Alyssa Vito, Karen Mossman
Cancers|November 13, 2021
Response to FEC Chemotherapy and Oncolytic HSV-1 Is Associated with Macrophage Polarization and Increased Expression of S100A8/A9 in Triple Negative Breast CancerAlyssa Vito, Nader El-Sayes, Omar Salem, et al.
International Journal of Molecular Sciences|June 2, 2021
Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast CancerAlyssa Vito, Stephanie Rathmann, Natalie Mercanti, et al.
International Journal of Molecular Sciences|February 15, 2022
A Combination of Chemotherapy and Oncolytic Virotherapy Sensitizes Colorectal Adenocarcinoma to Immune Checkpoint Inhibitors in a cDC1-Dependent MannerNader El-Sayes, Alyssa Vito, Omar Salem, et al.
Molecular Therapy Oncolytics|April 11, 2022
IFNAR blockade synergizes with oncolytic VSV to prevent virus-mediated PD-L1 expression and promote antitumor T cell activityNader El-Sayes, Scott Walsh, Alyssa Vito, et al.
Methods in Enzymology|March 4, 2020
Genetic modification of oncolytic viruses to enhance antitumor immunityMaria Eugenia Davola, Alyssa Vito, Jiarun Wei, et al.
Cancers|February 25, 2023
Oncolytic BHV-1 Is Sufficient to Induce Immunogenic Cell Death and Synergizes with Low-Dose Chemotherapy to Dampen Immunosuppressive T Regulatory CellsMaria Eugenia Davola, Olga Cormier, Alyssa Vito, et al.
Cancer Immunology Research|October 8, 2024
Level of Expression of MHCI-Presented Neoepitopes Influences Tumor Rejection by Neoantigen-Specific CD8+ T CellsLi Deng, Scott R Walsh, Andrew Nguyen, et al.
Pageof 2